Roche (OTCMKTS:RHHBY) Sees Unusually-High Trading Volume – What’s Next?

Shares of Roche Holding AG (OTCMKTS:RHHBY) saw strong trading volume on Tuesday . 8,258,749 shares changed hands during mid-day trading, an increase of 224% from the previous session’s volume of 2,552,043 shares.The stock last traded at $51.4150 and had previously closed at $51.41.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. TD Cowen reaffirmed a “hold” rating on shares of Roche in a research note on Tuesday, February 10th. The Goldman Sachs Group raised shares of Roche from a “sell” rating to a “hold” rating in a research note on Thursday, January 15th. Citigroup assumed coverage on shares of Roche in a research note on Tuesday, January 27th. They set a “buy” rating for the company. Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target for the company in a research note on Friday, April 24th. Finally, Argus raised shares of Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $51.50.

Roche Stock Performance

The company’s fifty day moving average is $51.26 and its 200-day moving average is $51.15. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38.

Hedge Funds Weigh In On Roche

Institutional investors and hedge funds have recently bought and sold shares of the company. Sentinel Trust Co. LBA acquired a new position in Roche during the 3rd quarter valued at about $878,000. Meritage Portfolio Management purchased a new stake in Roche in the fourth quarter valued at about $4,372,000. Vestmark Advisory Solutions Inc. purchased a new position in shares of Roche in the 3rd quarter valued at approximately $597,000. Hantz Financial Services Inc. boosted its stake in Roche by 164.9% in the 4th quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock worth $4,112,000 after purchasing an additional 49,633 shares in the last quarter. Finally, S&CO Inc. increased its stake in Roche by 2.5% during the 4th quarter. S&CO Inc. now owns 53,444 shares of the company’s stock valued at $2,767,000 after purchasing an additional 1,290 shares in the last quarter.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.